I am a DPhil Student in Psychiatry (supervised by Prof. Catherine Harmer and Prof. Philip Cowen) and a member of the Psychopharmacology and Emotion Research Laboratory (PERL) and the Oxford – Medical Research Council Doctoral Training Partnership.
I am interested in neurocognitive models of mood disorders and how they can explain important clinical features of depression, such as treatment effects, treatment resistance, or certain co-morbidities. My current research explores how novel and less established treatments for depression influence the processing of affective information. This includes non-pharmacological treatments, such as bright light exposure and specific mental exercises, as well as novel drug treatments.
I have a background in medicine as well as philosophy and cognitive science. I graduated from the Medical University of Vienna in 2015 as a medical doctor and subsequently went on to complete a master's degree in Mind, Language and Embodied Cognition at the University of Edinburgh (under the supervision of Prof. Andy Clark).
Currently, I am a member of Somerville College.
Kaltenboeck, A., Friedrich, F., Hinterbuchinger, B., Litvan, Z., Mossaheb, N. (2016): Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis. Neuropsychiatrie (in press).5
Hinterbuchinger B. et al, (2017), Schizophr Res
Kaltenboeck A. et al, (2016), Neuropsychiatr, 30, 223 - 226
Kaltenboeck A. et al, (2016), CNS Spectr, 21, 318 - 323
Self-medication with "bath salts" for symptoms of ADHD followed by severe psychosis and hyperkinetic symptoms
Kaltenboeck A. et al, (2014), The British Journal of Psychiatry (Letters to the Editor)
Schmid D. et al, (2012), J Nat Prod, 75, 870 - 875